Trial Profile
Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CT
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 02 Jun 2023
Price :
$35
*
At a glance
- Drugs [18F]FP-R01-MG-F2 (Primary)
- Indications COVID-19 pneumonia; Idiopathic pulmonary fibrosis; Primary sclerosing cholangitis
- Focus Diagnostic use
- 27 May 2023 Planned End Date changed from 14 Apr 2023 to 14 Apr 2025.
- 27 May 2023 Planned primary completion date changed from 14 Apr 2023 to 14 Apr 2025.
- 03 May 2022 Planned primary completion date changed from 14 Apr 2022 to 14 Apr 2023.